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Taurine is an essential amino acid in some mammals and is conditionally essential in humans.
Taurine is an abundant component of meat and ﬁsh-based foods and has been used as an
oral supplement in the treatment of disorders such as cystic ﬁbrosis and hypertension. The
purpose of this investigation was to identity the relative contributions of the solute trans-
portersinvolvedintaurineuptakeacrosstheluminalmembraneofhumanenterocytes.Distinct
transport characteristics were revealed following expression of the candidate solute trans-
porters in Xenopus laevis oocytes: PAT1 (SLC36A1) is a H+-coupled, pH-dependent, Na+-
and Cl−-independent, low-afﬁnity, high-capacity transporter for taurine and β-alanine; TauT
(SLC6A6) is a Na+-a n dC l −-dependent, high-afﬁnity, low-capacity transporter of taurine
and β-alanine; ATB0,+ (SLC6A14) is a Na+-a n dC l −-dependent, high-afﬁnity, low-capacity
t r a n s p o r t e rw h i c ha c c e p t sβ-alanine but not taurine. Taurine uptake across the brush-border
membrane of human intestinal Caco-2 cell monolayers showed characteristics of both PAT1-
and TauT-mediated transport. Under physiological conditions, Cl−-dependent TauT-mediated
uptake predominates at low taurine concentrations, whereas at higher concentrations typical
of diet, Cl−-independent PAT1-mediated uptake is the major absorptive mechanism. Real-time
PCR analysis of human duodenal and ileal biopsy samples demonstrates that PAT1, TauT and
ATB0,+ mRNA are expressed in each tissue but to varying degrees. In conclusion, this study is
the ﬁrst to demonstrate both taurine uptake via PAT1 and functional coexpression of PAT1 and
TauT at the apical membrane of the human intestinal epithelium. PAT1 may be responsible for
bulk taurine uptake during a meal whereas TauT may be important for taurine supply to the
intestinal epithelium and for taurine capture between meals.
(Received 1 October 2008; accepted after revision 15 December 2008; ﬁrst published online 22 December 2008)
Corresponding author C. M. H. Anderson: Institute for Cell and Molecular Biosciences, Faculty of Medical Sciences,
University of Newcastle upon Tyne, Newcastle upon Tyne NE2 4HH, UK. Email: catriona.anderson@ncl.ac.uk
Taurine is the most abundant free amino acid in the
humanbody.Ithasaubiquitousdistributionandaccounts
for approximately 0.1% of total body weight (Huxtable,
1992). The important functions of taurine are too
numerous to examine here but are described in detail
in a number of reviews (Hayes, 1988; Huxtable, 1992;
Sturman, 1993). In short, taurine has many fundamental
biological roles such as bile acid conjugation, anti-
oxidation, osmoregulation, membrane stabilization and
modulation of Ca2+ signalling, and is essential for
cardiovascular function, and development and function
of muscle, the retina and the central nervous system.
Endogenous taurine is synthesized mainly in the liver
and brain but is freely available for utilization from
carnivorous and omnivorous diets due to its abundant
expression in animal tissues. Indeed, taurine is an
essential amino acid in some carnivores (e.g. cats)
where, following domestication, a taurine-deﬁcient diet
is associated with retinal degeneration, cardiomyopathy,
high pregnancy failure, low neonate survival rate and
stunted growth (Hayes, 1988; Sturman, 1993). In man,
taurine is considered conditionally essential as it is
essential during development and is subsequently found
at high concentrations in breast milk, for example
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0.4mM in human, 0.8mM in mouse, 2.8mM in cats
(Sturman, 1993). It is recommended that synthetic
infant feeds are supplemented with taurine (Sturman,
1993). However, dietary taurine may also be essential in
adultsunderpathophysiologicalconditionswheresurgery,
trauma, critical illness and long-term total parenteral
nutrition (in both adults and children) are associated
with decreased taurine levels (Laidlaw & Kopple, 1987;
Paauw & Davis, 1990). The importance of dietary
taurine in pathophysiological conditions is emphasized
by its successful use as an oral supplement in various
clinical disorders including cystic ﬁbrosis (Darling et al.
1985), diabetes (Franconi et al. 1995) and hypertension
(Militante & Lombardini, 2002).
There are two intestinal transport mechanisms that
mediate taurine movement across the brush-border
membraneofthemammaliansmallintestine.Overrecent
years,thefocusofinvestigationofintestinaltaurinetrans-
port has been the high-afﬁnity, low-capacity Na+-a n d
Cl−-dependent transporter TauT (SLC6A6). cDNAs for
the TauT carrier have been isolated from a number of
speciesandtissuesincludingMDCK(canine)cells(Uchida
etal.1992),rat(Smithetal.1992),mouse(Liuetal.1992)
andhuman(Ramamoorthyetal.1994).Theclonedtrans-
porter has identical functional characteristics to the Na+-
andCl−-dependenttransportsystemfortheβaminoacids
taurine and β-alanine characterized using brush-border
membrane vesicles (BBMVs) from rat (Barnard et al.
1988) and rabbit (Miyamoto et al. 1989) small intestine.
This transport system has been named variously as the
β amino acid carrier or taurine transporter and has also
beencharacterizedintheintactintestinalepitheliumusing
either ﬂat sheets of intestine from rabbit, guinea pig and
rat small intestine (Munck & Munck, 1992, 1994), or
monolayers of the human intestinal epithelial cell line
Caco-2(Brandschetal.1995;Satsuetal.1997;Roig-P´ erez
et al. 2005). Comprehensive investigations of taurine and
β-alanine transport demonstrate that this high-afﬁnity,
very low-capacity carrier is the only transportmechanism
for taurine uptake in the rabbit and guinea pig small
intestine (Munck & Munck, 1992, 1994).
Earlier reports of intestinal taurine transport, using
intact sheets of rat small intestine, suggested that the
majorabsorptivemechanismfortaurinewasalow-afﬁnity
transporter (Munck, 1977, 1983). Munck and colleagues
identiﬁedthatthistaurineuptakeinratsmallintestinewas
via the partially Na+-dependent, but Cl−-independent,
imino acid carrier, a low-afﬁnity transport system with
a broad substrate speciﬁcity which is absent from guinea
pig and rabbit small intestine (Munck & Munck, 1994;
Munck et al. 1994; Anderson et al. 2004). Over the same
period, a low-afﬁnity H+-coupled transporter of a broad
range of amino acids was identiﬁed at the brush-border
membrane of human intestinal Caco-2 cell monolayers
and named system PAT, for proton-coupled amino acid
transporter (Thwaites et al. 1993, 1995). cDNA clones
for system PAT have been isolated from rat (Sagn´ e et al.
2001), mouse (Boll et al. 2002) and human (Chen et al.
2003). This system PAT-related carrier is now known as
PAT1 and is the ﬁrst of four members of solute carrier
family 36 (SLC36A1). Recent studies have shown that
the rat imino acid carrier and system PAT represent
the same transport system and that the partial Na+
dependence of the imino acid carrier observed in rat
small intestine is due to a functional coupling between
the H+-coupled transporter PAT1 and the Na+/H+
exchanger NHE3 (SLC9A3) such that the driving force
(the H+-electrochemical gradient) for PAT1-mediated
amino acid movement is maintained during absorption
viaNHE3-mediatedH+ efﬂux(Thwaitesetal.1995,1999;
Thwaites&Anderson,2007).Perhapstheearliestevidence
for β amino acid transport via this low-afﬁnity trans-
porter were the demonstrations of β-alanine absorption
in rat small intestine in vivo and in vitro (Schoﬁeld &
Lewis, 1947; Randall & Evered, 1964) that were both
pH dependent (uptake being stimulated as luminal pH
was decreased) and active (Thompson et al. 1970; De la
No¨ ue et al. 1971). PAT1 has been immunolocalized to
the brush-border membrane of human intestinal Caco-2
cell monolayers, and both human and rat small intestine
(Chen et al. 2003; Anderson et al. 2004). Thus, in
some species (e.g. human and rat) an alternative to the
well-characterized high-afﬁnity, low-capacity TauT trans-
port system is expressed at the luminal surface of the
small intestinal epithelium and this alternative carrier
maybeimportantinintestinalabsorptionwhentaurineis
presentathighconcentrationssuchasthosefoundinmeat
andﬁsh-basedfoods(Laidlawetal.1990;Huxtable,1992).
Theobjectivesofthisstudywerethreefold:todetermine
whether the two taurine transporters, PAT1 and TauT, are
coexpressed functionally in the same membrane surface;
to estimate the relative contribution of each to taurine
transport across the brush-border surface of conﬂuent
monolayers of the human intestinal epithelial cell line
Caco-2; to identify the tissue distribution of β amino
acid transporters in the human intestine which will aid
in predicting the likely role of each transporter (PAT1
(SLC36A1), TauT (SLC6A6) and ATB0,+ (SLC6A14)) in
absorptive transport along the length of the human
intestine. Part of this study was communicated to the
American Physiological Society at the Experimental
Biology 2008 meeting and was published in abstract form
(Anderson et al. 2008a).
Methods
Materials
[3H]Taurine (speciﬁc activity 27–29Cimmol−1)a n d
[3H]carnitine (speciﬁc activity 84Cimmol−1)w e r ef r o m
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GE Healthcare (Little Chalfont, UK). [3H]β-Alanine
(speciﬁc activity 50Cimmol−1) was from American
Radiolabelled Chemicals (St Louis, MO, USA).
Amino acid uptake in Xenopus laevis oocytes
Female Xenopus laevis were killed humanely by cervical
dislocation following Schedule 1 of the UK Animals
(Scientiﬁc Procedures) Act 1986. Oocytes were prepared
and injected with 50nl of either cRNA (1mgml−1)o r
water (as a control), as previously described (Anderson
et al. 2004). PAT1 (Anderson et al. 2004), ATB0,+
(Anderson et al. 2008b) and TauT (Ramamoorthy et al.
1994) cRNA were synthesized using either mMessage
mMachineT7orT7Ultrakits(Ambion,Warrington,UK).
Uptake of [3H]taurine or [3H]β-alanine (5μCi ml−1)
were measured 2–5days after injection and as
previously described (Anderson et al. 2004). Brieﬂy,
oocytes were washed in uptake solution and then uptake
measured at 22◦C for 40min. Uptake solution was
either NaCl-containing (100mM NaCl, 2 mM KCl, 1 mM
CaCl2,1 m M MgCl2,1 0 m M Hepes adjusted to pH7.4
with Tris base), Na+ free (NaCl replaced with choline
chloride) or Cl− free (chloride replaced with gluconate),
as appropriate. pH5.5 solutions were made by replacing
Hepes with Mes (10mM) and adjusting the pH with
Tris base. After uptake, oocytes were washed three times
in ice-cold buffer and lysed in 10% SDS. Radioactivity
associated with the lysate was measured by scintillation
counting.
Cell culture
Human intestinal Caco-2 cells (passage 104–127) were
grown as conﬂuent monolayers of polarized cells on
Transwell polycarbonate ﬁlters (Corning, Schiphol-Rijk,
the Netherlands), as previously described (Thwaites et al.
1993).Cellmonolayerswereused>14dayspost-seeding.
Amino acid uptake in Caco-2 cell monolayers
Caco-2 cell monolayers were washed (4 ×500ml) and
bathed in modiﬁed Krebs’ solution. Apical uptake
of [3H]taurine or [3H]β-alanine (0.5μCi ml−1)w e r e
measured over 15min at 37◦C in either NaCl-containing
(137mM NaCl, 5.4mM KCl, 1 mM MgSO4,0 . 3 4 m M
KH2PO4, 0.3mM NaH2PO4, 2.8mM CaCl2,1 0 m M
glucose, 10mM Hepes adjusted to pH7.4 with Tris base),
Na+-free(cholinechloridereplacingNaCl,andNaH2PO4
omitted) or Cl−-free (gluconate salts replacing chloride
salts) modiﬁed Krebs’ solutions. The pH of the apical
bathing solution was altered to pH5.5 or pH6.5 by
replacing Hepes with 10mM Mes and adjusting solution
pHwithTrisbase.Thebasolateralsolutionwasofthesame
composition as the apical solution but the pH was always
pH7.4. At the end of the uptake period the monolayers
were washed (3×500ml) in ice-cold solution, removed
from the plastic inserts and cell monolayer-associated
radioactivity measured by scintillation counting.
Real-time PCR: a human gastrointestinal tract
cDNA panel and human mucosal biopsy samples
The abundance of PAT1, TauT and ATB0,+ cDNAs in
a human intestinal cDNA panel and human mucosal
biopsy samples was determined by quantitative real-time
PCR on a LightCycler480 (Roche) and normalized to
glyceraldehyde-3-phosphate dehydrogenase (GAPDH).
Duodenal (Walters et al. 2006) and ileal (Balesaria et al.
2008) mucosal endoscopic biopsies (where ≥3 biopsies
were pooled per patient) were obtained separately
from two cohorts of control patients at Hammersmith
Hospital (London, UK) undergoing investigation for
diagnostic purposes and obtained with patient consent
and local ethical approval (for full details see Walters
et al. 2006; Balesaria et al. 2008). RNA was extracted
using the SV Total RNA extraction kit (Promega,
Southampton, UK). Concentration and purity of RNA
was quantiﬁed (Nanodrop 1000, ThermoScientiﬁc)
and RNA integrity checked by electrophoresis on a
1% agarose formaldehyde gel stained with ethidium
bromide.Reversetranscription(RT)wasperformedusing
M-MLV RNase H+ Reverse Transcriptase (Promega).
A human gastrointestinal tract multiple tissue cDNA
panel was purchased from Clontech. For real-time PCR,
a standard curve (plot of concentration versus crossing
point, with efﬁciency approaching 2 (>1.9) and r value
of >0.99) was established for each target gene using
appropriate cloned cDNAs (quantiﬁed and assessed
for purity using a Nanodrop 1000). HPLC-puriﬁed
oligonucleotide primers were: PAT1 (NM 078483)
forward CATAACCCTCAACCTGCCCAAC, reverse
GGGACGTAGAACTGGAGTGC; TauT (NM 003043)
forward TATCTGTATCCTGACATCACCCG, reverse
CCCAGGCAGATGGCATAAGAG; ATB0,+ (NM 007231)
forward CTTCTGGCTTGGCTCATAG, reverse
TGAAGCACCCTCCAGAGTTGC. GAPDH primers
were purchased from PrimerDesign (Southampton, UK).
PCR reactions contained 0.5μM each primer, 1μlc D N A
(panel samples) or 2μl RT product (biopsy samples) in
1×LightCycler480 SYBR Green 1 Master (Roche) in
a total reaction volume of 20μl. PCR was performed
over 35–45 cycles and included an initial hot start (95◦C,
2min), denaturation (94◦C, 5s), annealing (57–60◦C,
15s) and extension (72◦C, 20s). Fluorescence was
measured at the end of the extension step in each cycle.
Following cycling, melt curve analysis was performed
over the temperature range 60–90◦C to conﬁrm unique
ampliﬁcation of the desired product. Products from
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preliminary PCR ampliﬁcations for each template were
characterized by cloning and sequencing. PCR analyses
were performed in duplicate for each sample. Results
are expressed as mRNA abundance relative to GAPDH
(pg/ng GAPDH).
Figure 1. β amino acid uptake in PAT1-, TauT- or
ATB0,+-expressing oocytes
Uptake of [3H]taurine (A)a n d[ 3H]β-alanine (B) into oocytes injected
with PAT1, TauT or ATB0,+ cRNA (ﬁlled bars). For PAT1, β-alanine and
taurine (10 μM) uptakes were measured at pH 5.5 in the absence of
extracellular Na+. For TauT and ATB0,+, β-alanine and taurine (2 μM),
uptakes were measured at pH 7.4 in the presence of extracellular Na+.
As a control, uptake into water-injected oocytes (open bars) was
measured under identical conditions in all cases. Data are
mean ± S.E.M.( n = 15–30). NS, P > 0.05; ∗∗∗, P < 0.001; all versus
water-injected oocytes.
Statistics
Data are expressed as mean± S.E.M. Statistical
comparisons of mean values were made using unpaired
Student’s two-tailed t test or one-way ANOVA (with
Tukey–Kramer or Bonferroni’s multiple comparisons
posttest) as appropriate. Curves were ﬁtted using FigP
software or GraphPad Prism 4. Signiﬁcance was assumed
if P <0.05.
Results
Uptakeofthetwoβaminoacids[3H]taurine(Fig.1A)and
[3H]β-alanine(Fig.1B)issigniﬁcantlygreater(P<0.001)
in both PAT1- and TauT-injected oocytes compared to
water-injected oocytes demonstrating that taurine and
β-alanine are substrates for both PAT1 and TauT.
It should be noted that an additional transporter for
β-alanineisexpressedinrabbitileumwhichwasoriginally
known as the β-alanine carrier (Munck, 1985; Munck
& Munck, 1992). cDNAs for this transporter have been
isolated (Sloan & Mager, 1999; Nakanishi et al. 2001)
and it is now known as ATB0,+ (SLC6A14), a Na+-a n d
Cl−-dependent transporter of both dipolar and cationic
aminoacidswhichhasalowafﬁnityforβ-alanine(Sloan&
Mager,1999;Nakanishietal.2001;Andersonetal.2008b).
We have recently demonstrated that β-alanine trans-
port via ATB0,+ has the same functional characteristics
as those described in rabbit ileum for the β-alanine
carrier (Anderson et al. 2008b). Although β-alanine is a
substrate for ATB0,+ (Fig.1B), in contrast to PAT1 and
TauT,theuptakeoftaurineintoATB0,+-expressingoocytes
isonlyslightlygreaterthanthatobservedinwater-injected
oocytes (Fig.1A) suggesting that taurine is excluded or is
a very poor substrate for this third intestinal transporter
of β amino acids.
Taurine uptake by both PAT1 and TauT is via saturable
carrier-mediatedtransportprocesses(Fig.2)withdistinct
functional characteristics. Saturable, pH-dependent,
Na+-independent taurine uptake via PAT1 demonstrates
that PAT1 has a relatively low afﬁnity for taurine
(K m 7.5±3.0mM,F i g . 2 A). In contrast, Na+-a n d
Cl−-dependent taurine uptake via TauT conﬁrms that
TauT has a high afﬁnity for taurine (K m 6.9±1.8μM,
Fig.2B)( L i uet al. 1992; Smith et al. 1992; Uchida et al.
1992; Ramamoorthy et al. 1994). At 100μM taurine,
taurine uptake via TauT is essentially saturated (Fig.2B).
The distinct ion-dependency of β amino acid uptake
via these two transporters is demonstrated in Fig.3.
β-Alanine uptake via PAT1 is increased by a decrease
in extracellular pH (P<0.001), and is independent of
both Na+ and Cl− (Fig.3A). In contrast, β amino
acid uptake via TauT is highly dependent upon both
Na+ and Cl− (P<0.001) (Liu et al. 1992; Smith et al.
1992; Uchida et al. 1992; Ramamoorthy et al. 1994)
C   2009 The Authors. Journal compilation C   2009 The Physiological SocietyJ Physiol 587.4 Intestinal taurine transport via PAT1 (SLC36A1) and TauT (SLC6A6) 735
and is slightly but not signiﬁcantly (P>0.05) reduced
upon extracellular acidiﬁcation (Fig.3B). Under optimal
conditions for each transporter, clear differences in
substrate selectivity can be observed (Fig.4). Low-afﬁnity
PAT1-mediated [3H]β-alanine uptake (pH5.5, Na+-free
conditions) can be inhibited by the two β amino acids
taurine and β-alanine (10mM)a sw e l la st h ek n o w n
PAT1 substrates proline and MeAIB (Thwaites et al.
1995; Chen et al. 2003; Anderson et al. 2004) (Fig.4A).
In contrast, high-afﬁnity TauT-mediated [3H]β-alanine
uptake (pH7.4, in the presence of Na+ and Cl−)
is signiﬁcantly inhibited (P<0.001) by taurine and
β-alanine (500μM) whereas proline and MeAIB were
without effect (500μM,b o t hP >0.05, Fig.4B). In
Figure 2. Concentration-dependent taurine uptake in PAT1- or
TauT-expressing oocytes
Concentration-dependent [3H]taurine uptake was measured into
oocytes injected with cRNA for PAT1 (A) and TauT (B). Uptake into
PAT1-expressing oocytes was measured in Na+-free solutions at
extracellular pH 5.5. Uptake into TauT-expressing oocytes was
measured in NaCl-containing solutions at extracellular pH 7.4. Under
each condition, uptake in water-injected oocytes was subtracted from
that in cRNA-injected oocytes to give either PAT1- or TauT-speciﬁc
uptake. Michaelis–Menten kinetics are ﬁtted to the data which are
mean ± S.E.M.( n = 7–10).
additional experiments, MeAIB had no effect on uptake
of either taurine or β-alanine in TauT-expressing oocytes
even at concentrations (30mM MeAIB) that would
completely inhibit PAT1-mediated transport (data not
shown). These observations demonstrate that TauT has
a clear preference for β amino acids. For comparison, the
effectsoftwohigh-afﬁnityATB0,+ substrates,leucine(K m
Figure 3. Distinct ion dependency of β amino acid uptake in
PAT1- and TauT-expressing oocytes
A,[ 3H]β-alanine (10 μM) uptake was measured into PAT1
cRNA-injected oocytes at pH 5.5 in the presence of NaCl or in
Na+-free (–Na+)o rC l −-free (–Cl−) conditions, and at pH 7.4 under
Na+-free (–Na+) conditions. Uptake in water-injected oocytes was
subtracted from that in cRNA-injected oocytes to give PAT1-speciﬁc
uptake. Data are mean ± S.E.M.( n = 17–18). NS, P > 0.05; ∗∗∗,
P < 0.001; all versus pH 5.5 –Na+. B, [3H]β-alanine (2 μM) uptake was
measured into TauT cRNA-injected oocytes at pH 7.4 in the presence
of NaCl or in Na+-free (–Na+)o rC l −-free (–Cl−) conditions, or at
pH 5.5 in the presence of NaCl. Uptake in water-injected oocytes was
subtracted from that in cRNA-injected oocytes to give TauT-speciﬁc
uptake. Data are mean ± S.E.M.( n = 9–10). NS, P > 0.05; ∗∗∗,
P < 0.001; all versus pH 7.4 NaCl.
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12μM) and lysine (K m 100μM) (Sloan & Mager, 1999),
were investigated. At concentrations that would typically
be saturating for either PAT1 or TauT substrates, leucine
and lysine are unable to inhibit either transport system
(P>0.05, Fig.4A and B).
Figure 4. Inhibition of PAT1- or TauT-mediated β amino acid
uptake by unlabelled amino acids
A, the ability of various amino acids and the amino acid analogue
MeAIB (all 10 mM) to inhibit [3H]β-alanine (10 μM) uptake into
PAT1-expressing oocytes was measured in Na+-free pH 5.5 solutions.
Uptake in water-injected oocytes was subtracted from that in
cRNA-injected oocytes to give PAT1-speciﬁc uptake. Data are
mean ± S.E.M.( n = 19–20). NS, P > 0.05; ∗∗∗, P < 0.001; all versus
Control. B, the ability of various amino acids and the amino acid
analogue MeAIB (all 500 μM) to inhibit [3H]β-alanine (2 μM) uptake
into TauT-expressing oocytes was measured in NaCl-containing pH 7.4
solutions. Uptake in water-injected oocytes was subtracted from that
in cRNA-injected oocytes to give TauT-speciﬁc uptake. Data are
mean ± S.E.M.( n = 16–20). NS, P > 0.05; ∗∗∗, P < 0.001; all versus
Control.
We have identiﬁed clear functional differences for β
amino acid transport via the cloned transporters PAT1
and TauT (Figs1–4). Firstly, the afﬁnity for taurine differs
by a 1000-fold (Fig.2) so that even at concentrations
below the K m for PAT1, taurine transport via TauT will
be saturated. Secondly, PAT1 functions as a H+-coupled,
pH-dependent, Na+-a n dC l −-independent transporter
whereasTauTisaNa+-andCl −-coupledtransportsystem
(Fig.3).Thirdly,TauTishighlyselectiveforβaminoacids
whereasPAT1acceptsβaminoacidsandotheraminoacids
(e.g. proline and MeAIB) with similar afﬁnity (Fig.4).
The question arises as to which of these transporters
mediates taurine uptake across the luminal surface of the
human small intestine. Therefore, the next stage in this
investigation was to exploit the distinctive characteristics
of these two transporters to identify whether or not PAT1
andTauTarefunctionallycoexpressedatthebrush-border
membrane of intact monolayers of the human intestinal
epithelial cell line Caco-2 and to identify the relative
contribution of these two transport systems to taurine
uptake. The results in Fig.5 demonstrate that both PAT1
and TauT can mediate taurine uptake across the apical
membrane of human intestinal Caco-2 cell monolayers
if measured under conditions that favour transport via
eachindividualtransportsystem.[3H]Taurineuptakewas
ﬁrstmeasuredunderconditionsthatwillfavourtransport
via the low-afﬁnity H+-coupled, Na+-independent, PAT1
(pH5.5,Na+-freesolutions,hightaurineconcentrationof
100μM)( F i g .5 A and B). Under these conditions, where
Na+-dependent TauT will not function, [3H]taurine
uptake has all the characteristics of PAT1 being increased
as luminal pH is reduced from pH7.4 to 5.5, and being
inhibited by β-alanine and proline (both 10mM,F i g .5 A).
This pH-dependent, Na+-independent, taurine uptake
across the apical membrane of Caco-2 cell monolayers
is saturable with similar afﬁnity (K m 10.1±1.2mM,
V max 47200±2300pmolcm−2 (15min)−1,F i g . 5 B)t o
that observed using PAT1-expressing oocytes (Fig.2A).
In contrast, when [3H]taurine uptake is measured under
conditions that will favour transport via the high-afﬁnity
TauT (pH7.4, Na+-a n dC l −-containing solutions, low
taurine concentration of 0.1μM), a separate trans-
port function can be identiﬁed (Fig.5C). Under these
conditions (0.1μM taurine, apical pH7.4), where PAT1
function will be minimal, [3H]taurine uptake has all the
characteristics of TauT, transport being abolished in the
absenceofNa+ andCl−,andbeingselectivelyinhibitedby
β-alanine (500μM, P <0.001) but not proline (500μM,
P >0.05, Fig.5C). It is possible to ﬁt Michaelis–Menten
kinetics to a single saturable component over the
taurine concentration range 0.1–50μM with an afﬁnity
similar to that identiﬁed for TauT (K m 12.9±1.3μM,
V max 232±9pmolcm −2 (15min)−1,F i g .5 D). However,
if the taurine concentration range used is extended
to 0.1–200μM, a second low-afﬁnity component is
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revealed(thenon-linearEadie-Hofsteeplot,Fig.5Dinset),
suggesting that both TauT and PAT1 contributeto taurine
uptake even under the TauT-favouring conditions.
Thus, although it is apparent that either PAT1 or
TauT can mediate taurine uptake across the brush-border
Figure 5. Functional characteristics of taurine uptake across the brush-border membrane of human
intestinal (Caco-2) cell monolayers demonstrate the involvement of both PAT1 and TauT
A, to demonstrate H+-coupled, pH-dependent, Na+-independent, PAT1-mediated transport, [3H]taurine uptake
across the apical membrane of Caco-2 cell monolayers was measured at an extracellular taurine concentration of
100 μM under Na+-free conditions at apical pH 5.5 and 7.4 (basolateral pH 7.4). At pH 5.5, [3H]taurine uptake
was measured in the presence and absence of the PAT1 substrates β-alanine and proline (both 10 mM). Data are
mean ± S.E.M.( n = 10). ∗∗∗, P < 0.001; all versus pH 5.5. B, concentration-dependent PAT1-mediated [3H]taurine
uptake (0.1–30 mM taurine) was measured at apical pH 5.5 in the absence of extracellular Na+ (TauT will be
inactive under these conditions). Michaelis–Menten kinetics are ﬁtted to the data which are mean ± S.E.M.( n = 6).
Inset, Eadie–Hofstee plot: V, taurine uptake; S, taurine concentration. C, to demonstrate Na+-a n dC l −-dependent
TauT-mediated transport, [3H]taurine uptake across the apical membrane of Caco-2 cell monolayers was measured
at an extracellular concentration of 0.1 μM taurine at apical pH 7.4 in NaCl-containing solutions and in the absence
of extracellular Na+ (–Na+)o rC l − (–Cl−) (basolateral pH 7.4). In the presence of both Na+ and Cl−,[ 3H]taurine
uptake was measured in the presence and absence of the TauT substrate β-alanine (500 μM) or proline (500 μM)
which is excluded from TauT at this concentration. Data are mean ± S.E.M.( n = 10). NS, P > 0.05; ∗∗∗, P < 0.001;
all versus NaCl. D, concentration-dependent TauT-mediated [3H]taurine uptake (0.0001–0.05 mM taurine) was
measured at apical pH 7.4 in NaCl-containing solutions. Michaelis–Menten kinetics are ﬁtted to the data which
are mean ± S.E.M.( n = 6). Inset, Eadie–Hofstee plot (ﬁlled symbols represent data in main panel D over taurine
concentration range 0.0001–0.05 mM; open symbols represent data for uptake at 0.1 and 0.2 mM): V,t a u r i n e
uptake; S, taurine concentration.
membrane of these human enterocytes under certain
conditions, it is unclear what the relative contributions
of the two transport mechanisms are under physio-
logical conditions. Measurements made using pH micro-
electrodeshaveidentiﬁedanareaoflowpHattheluminal
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surface of the mammalian small intestine where the
s u r f a c ep Hi nt h ej e j u n u mi si nt h er a n g ep H 6 . 2 – 6 . 7
(McEwan et al. 1988; Daniel et al. 1989). To determine
the relative contribution of the two transporters to
taurineinﬂux,[3H]taurineuptakewasthereforemeasured
under pseudo-physiological conditions (apical pH6.5,
in the presence of extracellular Na+)o v e rar a n g eo f
luminal taurine concentrations (0.1μM to 1 mM)i nt h e
presenceandabsenceofextracellularCl−(Fig.6).Removal
of extracellular Cl− selectively inhibits TauT-mediated
uptake (Fig.3B) but does not affect transport via PAT1
(Fig.3A).Itshouldbenotedthataminoacidtransportvia
PAT1andTauTinintactepitheliacannotbedistinguished
by removal of extracellular Na+.P A T 1a c t i v i t yi ni n t a c t
epithelia is dependent upon NHE3 function resulting in
partial Na+ dependence (Anderson et al. 2004; Anderson
& Thwaites, 2005).
At 0.1 μM taurine, 80% of taurine uptake was inhibited
by removal of Cl−, uptake being 2.44±0.27 and
0.48±0.06pmolcm−2 (15min)−1 (P<0.001) in the
presence and absence of extracellular Cl−, respectively.
This Cl− dependence suggests that the majority of
taurine uptake (at 0.1μM taurine) is via the high-afﬁnity
Cl−-dependentTauT(Fig.6).However,astheextracellular
taurine concentration increases, the degree of Cl−
dependence decreases suggesting that, at higher substrate
Figure 6. The relative contributions of PAT1 and TauT to total
taurine uptake across the brush-border membrane of human
intestinal (Caco-2) cell monolayers varies with the luminal
taurine concentration
Taurine (0.0001–1 mM) uptake across the apical membrane of Caco-2
cell monolayers was measured at the physiological apical pH of 6.5
(basolateral pH 7.4) in the presence and absence of extracellular Cl−.
Removal of extracellular Cl− will selectively inhibit TauT whereas PAT1
will remain active. At each extracellular taurine concentration, taurine
uptake is expressed as a percentage of the total uptake in the
presence of Cl−. The PAT1-mediated component is taken as the
uptake in the absence of Cl− (ﬁlled columns) and the TauT-mediated
component is the difference between uptake in the presence and
absence of Cl− (open columns). Data are mean ± S.E.M.( n = 10).
concentrations, taurine uptake is mediated primarily
via the low-afﬁnity Cl−-independent PAT1, such that at
100μMand1mMtaurinethereisnosigniﬁcantdifference
(P>0.05) between uptake in the presence (total uptake
at apical pH6.5) and absence of Cl−. PAT1-mediated
(Cl−-independent) taurine uptake represents 79% and
88%oftotaluptakeatextracellulartaurineconcentrations
of100μMand1mM,respectively(Fig.6).At1mMtaurine,
uptake was 4251±379 and 3746±366pmolcm−2
(15min)−1 in the presence and absence of extracellular
Cl−, respectively (Fig.6). The residual Cl−-dependent
component (appproximately 500pmolcm−2 (15min)−1)
is broadly consistent with the estimate of the maximal
capacity of TauT in Fig.5D. Therefore, the relative
contribution of PAT1 will continue to increase at
increasing extracellular taurine concentrations whereas
the magnitude of TauT-mediated transport will remain
constant (above saturating levels) but will decrease as a
proportion of total taurine uptake (Fig.6).
The third intestinal transporter of β amino acids is
ATB0,+.H o w e v e r ,A T B 0,+ will play no role in taurine
absorptionas,whenexpressedinXenopus oocytes,ATB0,+
transports β-alanine but not taurine (Fig.1). ATB0,+
has a distinct substrate selectivity, compared to either
TauT or PAT1 (Fig.4), as [3H]β-alanine uptake into
ATB0,+-expressingoocytesisinhibitedby2mMlysineand
leucine (both P <0.001) but not taurine or MeAIB (both
P >0.05, Fig.7A). To identify if ATB0,+ can contribute to
β-alanine uptake across the brush-border membrane of
human intestinal Caco-2 cell monolayers, [3H]β-alanine
uptake was measured under conditions favouring the
function of both ATB0,+ and TauT (NaCl-containing
solutions, apical pH7.4, 0.1μM β-alanine) (Fig.7B).
[3H]β-Alanine uptake is both Na+-a n dC l −-dependent
(Fig.7B)consistentwithuptakeviaeitherTauTorATB0,+.
In addition, [3H]β-alanine uptake was measured in the
presence and absence of amino acids at concentrations
that selectively inhibit ATB0,+, TauT or PAT1. Neither the
ATB0,+ substratesleucineorlysine(2.5mM),northePAT1
substrateMeAIB(30mM),hadanyeffecton[3H]β-alanine
uptake (all P >0.05) whereas taurine (500μM) caused
signiﬁcant inhibition (P<0.001, Fig.7B). These data are
consistent with β-alanine uptake under these conditions
(wherePAT1functionwillbeminimal)beingviaTauTand
not ATB0,+.T h el a c ko fA T B 0,+ function at the luminal
surface of these human intestinal cells is also suggested
by the inability of an excess of the ATB0,+ substrate
lysine (2.5mM) to inhibit the uptake of the ATB0,+
substrate [3H]carnitine (10μM) (Nakanishi et al. 2001),
uptake being 14.88±1.29 and 16.56±0.37pmolcm−2
(15min)−1 in the absence and presence of lysine,
respectively (n=6) (P>0.05).
As observed for taurine uptake (Fig.5C), the lack
of effect of MeAIB demonstrates that PAT1 does not
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Figure 7. ATB0,+ has a distinct substrate selectivity, compared
to PAT1 and TauT, and does not contribute to β-alanine uptake
across the brush-border membrane of human intestinal (Caco-2)
cell monolayers
A,[ 3H]β-alanine (100 μM) uptake into ATB0,+-expressing oocytes was
measured in NaCl-containing, pH 7.4 solutions in the presence and
absence of various amino acids and the amino acid analogue MeAIB
(all 2 mM). Uptake in water-injected oocytes was subtracted from that
in cRNA-injected oocytes to give ATB0,+-speciﬁc uptake. Data are
mean ± S.E.M.( n = 16–20). NS, P > 0.05; ∗∗∗, P < 0.001; all versus
Control. B:[ 3H]β-alanine uptake across the brush-border membrane
of Caco-2 cell monolayers was measured under conditions favourable
for both TauT and ATB0,+ function (0.1 μM β-alanine, pH 7.4
NaCl-containing apical solution). [3H]β-Alanine uptake was measured
in the presence (NaCl) or absence of either Na+ (–Na+)o rC l − (–Cl−).
[3H]β-Alanine uptake was also measured at pH 7.4 in the presence of
NaCl and in the presence and absence of various amino acids at
contribute signiﬁcantly to [3H]β-alanine uptake across
the brush-border membrane of Caco-2 cell monolayers
under the TauT-favouring conditions (NaCl-containing
solutions, apical pH7.4, 0.1μM β-alanine). However, if
[3H]β-alanine uptake across the brush-border membrane
of Caco-2 cell monolayers is measured under conditions
favouring PAT1 function (pH5.5, Na+-free solutions,
substrateconcentrationof100μM),[3H]β-alanineuptake
displays PAT1 characterictics being increased as pH is
reduced from pH7.4 to 5.5 and being inhibited by
30mM MeAIB (Fig. 7C). Thus, both TauT and PAT1 (but
not ATB0,+)c o n t r i b u t et oβ-alanine uptake across the
b r u s h - b o r d e rm e m b r a n eo fC a c o - 2c e l lm o n o l a y e r sa n d ,
asobservedfortaurine(Fig.6),therelativecontributionof
each is probably dependent upon substrate concentration
and the ionic composition of the local microenvironment
bathing the luminal surface of the small intestinal
epithelium.
Relative quantitative real-time RT-PCR was used to
assessthedistributionofPAT1,TauTandATB0,+ alongthe
proximal–distal axis of the human gastrointestinal tract.
Consistent with the functional measurements described
in Figs5–7, real-time PCR using Caco-2 mRNA detected
transcripts for both PAT1 (420±160pgng−1 GAPDH)
and TauT (26±8pgng −1 GAPDH) whereas ATB0,+ was
essentially undetectable. Samples from a commercial
human gastrointestinal tract cDNA panel, in which
each sample comprises a pool of cDNAs from multiple
donors, were assayed in duplicate (Fig.8A–C). Results are
expressed relative to GAPDH mRNA. All transcripts were
found in the stomach and throughout the length of the
intestine, from duodenum to descending colon (Fig.8).
PAT1wasmostabundantinthejejunum,whereexpression
was approximately 1.5-fold higher than elsewhere in the
intestine (Fig.8A) .T h e s eo b s e r v a t i o n sa r es i m i l a rt oa
previous study when mRNA levels were detected by
Northern blot (Chen et al. 2003). TauT appears to be
similarly distributed, although expression in ascending
colon was notably less than in other regions (Fig.8B).
In contrast, there were signiﬁcant regional differences in
ATB0,+ expression. It was most abundant in stomach,
duodenum and descending colon (duodenum 2.2-fold
higher than descending colon), and was lower in all other
concentrations that discriminate between function of ATB0,+,T a u T
and PAT1: 2.5 mM leucine (to inhibit ATB0,+); 2.5 mM lysine (to inhibit
ATB0,+); 500 μM taurine (to inhibit TauT); 30 mM MeAIB (to inhibit
PAT1). Data are mean ± S.E.M.( n = 12). NS, P > 0.05; ∗∗∗, P < 0.001;
all versus NaCl. C, pH-dependent PAT1-mediated β-alanine uptake
across the apical membrane of Caco-2 cell monolayers is observed
when [3H]β-alanine uptake is measured under conditions favourable
for PAT1 function (100 μM β-alanine, apical pH 5.5, Na+-free
solutions). Inhibition of [3H]β-alanine uptake was observed in the
presence of the PAT1 substrate MeAIB (30 mM). Data are
mean ± S.E.M.( n = 11–12). ∗∗∗, P < 0.001; versus –Na+ pH 5.5.
C   2009 The Authors. Journal compilation C   2009 The Physiological Society740 C. M. H. Anderson and others J Physiol 587.4
samples (Fig.8C). This higher (relative to other regions
of the gastrointestinal tract) ATB0,+ mRNA expression in
stomach has been observed previously in human tissues
(Sloan&Mager,1999).Inthesmallintestinetherelatively
high expression levels of ATB0,+ in duodenum, compared
to jejunum and ileum, contrast with observations of
mRNA distribution in mouse where greater transcipt
levels are found in ileum (Nakanishi et al. 2001; Hatanaka
et al. 2002). mRNA abundance of each transcript was
also measured in a set of human duodenal (n=4–5)
and ileal (n=8) biopsies (Fig.8D–F). In contrast to
the commercial tissue panel samples where RNA was
extracted from all layers of the intestinal wall, endo-
scopic biopsies comprise mucosa including villus and
crypt down to the submucosa layer but exclude muscle
layers. All transcripts were readily detected in all samples.
Comparison of the two groups showed that, in agreement
with the results from the panel samples, PAT1 expression
Figure 8. Real-time PCR detection of PAT1, TauT and ATB0,+ transcripts in a human gastrointestinal tract
cDNA panel and human mucosal biopsy samples
Expression of PAT1, TauT and ATB0,+ transcripts in a human gastrointestinal tract cDNA panel (A–C) and human
mucosal biopsy samples (D–F). The tissues investigated were stomach (Stom), duodenum (Duo), jejunum (Jej),
ileum (Ile), ascending colon (Asc), transverse colon (Tran) and descending colon (Des). The cDNA panel samples
each comprised a pool of cDNAs from multiple donors and were assayed in duplicate whereas human duodenal
mucosal biopsy samples were n = 4–5 (individual patients) and ileal samples n = 8 (individual patients). Data
are expressed as mRNA abundance relative to GAPDH (pg/ng GAPDH). NS, P > 0.05; ∗∗, P < 0.01; all versus
duodenum.
did not differ (P>0.05) between duodenum and ileum
(Fig.8D). Biopsy data for TauT and ATB0,+ contradicted
that obtained from the commercial panel with TauT
transcript levels being signiﬁcantly greater (P<0.01)
in ileum than duodenum (Fig.8E)w h e r e a sA T B 0,+
expression was similar in duodenum and ileum (Fig.8F).
In general, ATB0,+ expression in the biopsy samples was
comparable to those in the panel whereas both PAT1 and
TauTmRNAsweremoreconcentratedinthebiopsies.The
differences between panel samples and biopsies probably
reﬂect the difference in tissue source (whole wall versus
m u c o s a )o ft h et w os e t so fs a m p l e s .
Discussion
Distinct functional characteristics of β amino acid
transport via the cloned transporters PAT1, TauT and
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ATB0,+ aredemonstratedfollowingexpressioninXenopus
laevis oocytes (Figs1, 2, 3, 4 and 7). The functional
characteristics of the three transporters vary in ion
dependency, substrate speciﬁcity and substrate afﬁnity,
such that each can be identiﬁed as follows: PAT1 is a
H+-coupled, pH-dependent, Na+-a n dC l −-independent,
low-afﬁnity, high-capacity transporter for both taurine
and β-alanine; TauT is a Na+-a n dC l −-dependent,
high-afﬁnity,low-capacitytransporterofbothtaurineand
β-alanine (Liu et al. 1992; Smith et al. 1992; Uchida et al.
1992; Ramamoorthy et al. 1994); ATB0,+ is a Na+-a n d
Cl−-dependent, high-afﬁnity, low-capacity transporter of
neutral(e.g.leucine)andcationic(e.g.lysine)aminoacids
which accepts β-alanine with low afﬁnity but excludes
taurine (Anderson et al. 2008b).
As stated above, the focus of attention in intestinal
taurine transport studies over recent years has been
the high-afﬁnity, low-capacity Na+-a n dC l −-dependent
transporter TauT (for examples see Barnard et al. 1988;
Miyamoto et al. 1989; Brandsch et al. 1995; Satsu et al.
1997; Roig-P´ erez et al. 2005). The potential contribution
of a low-afﬁnity, high-capacity transport system for β
amino acids has not been addressed which is perhaps
a little surprising considering the high concentration of
taurine found in many carnivorous/omnivorous diets.
However, there is evidence for such a transporter in both
ratsmallintestineandhumanintestinalCaco-2cellmono-
layers (Thwaites et al. 1993, 1995, 1999; Munck et al.
1994; Thwaites & Stevens, 1999). Following the molecular
identiﬁcation of PAT1 as a low-afﬁnity transporter of
iminoandaminoacidsinratandhuman(Sagn´ eetal.2001;
Chen et al. 2003), and immunolocalization of PAT1 to the
luminal surface of human intestinal Caco-2 cell mono-
layers and human and rat small intestine (Anderson et al.
2004),weproposedthatapotentialphysiologicalfunction
of PAT1 was to allow efﬁcient utilization of taurine in
specieswithanabundanceoftaurineinthediet(Anderson
et al. 2004).
This study provides the ﬁrst demonstration of taurine
uptakeviaaPAT1transporterexpressedinisolation(Figs1
and 2). In addition, we provide the ﬁrst demonstration
that both PAT1 and TauT are functionally coexpressed
at the brush-border membrane of intact monolayers of
the human intestinal epithelial cell line Caco-2. It is
also evident that the relative contribution of each trans-
port system to total intestinal taurine transport will
vary depending upon local conditions including taurine
concentration and the ionic composition (Na+,C l − and
H+) of the solution bathing the mucosal surface of
the enterocyte. Under physiological conditions (apical
pH6.5, NaCl-containing solutions), both transporters
will mediate taurine uptake across the brush-border
membrane with TauT being the dominant transporter
at low extracellular taurine concentrations whereas PAT1
will mediate the bulk of taurine uptake at concentrations
above10μM(whichisaroundtheK m ofTauTfortaurine)
(Fig.6).TherelativeimportanceofPAT1willthusincrease
asluminaltaurineconcentrationsincreasesuggestingthat
PAT1 may mediate the bulk of taurine absorption from
taurine-rich meals (e.g. meat and ﬁsh; Laidlaw et al.
1990), taurine-containing energy drinks (which contain
approximately 30mM taurine), and the large doses used
in clinical trials (Darling et al. 1985; Franconi et al. 1995;
Militante & Lombardini, 2002).
The presence of two taurine transporters in the human
smallintestineissimilartoobservationsmadeinratsmall
intestine(Munck&Munck,1994;Muncketal.1994).Both
Cl−-dependent (via the high-afﬁnity, low-capacity TauT)
and Cl−-independent (via the imino acid carrier/PAT1)
β amino acid transporters were detected in rat small
intestine with the Cl−-independent, PAT1-mediated
component being the dominant mechanism even at
taurine and β-alanine concentrations as low as 5μM
(Munck & Munck, 1994). In contrast to the observations
in rat small intestine, there is no evidence for a PAT1
componentoftaurineuptakeinrabbitorguineapigsmall
intestine where taurine uptake appears to be mediated
solely by TauT (Munck & Munck, 1992, 1994). Thus,
there are clear species differences in the complement of
amino acid transport systems expressed at the luminal
surface of the small intestinal epithelium. This species
variability is also evident for ATB0,+.W ew e r eu n a b l et o
detect ATB0,+ function in human intestinal Caco-2 cell
monolayers (Fig.7). A previous report (Hu & Borchardt,
1992) has suggested that ATB0,+ may be responsible for
Na+-dependent phenylalanine uptake in Caco-2 cells but
thelowafﬁnity(K m2.7mM)andpoorinhibitionby10mM
lysine (a concentration 100-fold greater than the K m for
lysine;Sloan &Mager,1999)reportedsuggestthatATB0,+
isnotinvolved.IncontrasttothelackofATB0,+ inCaco-2
cells, ATB0,+ is the predominant transport system for
β-alanine in some other intestinal tissues, for instance,
rabbit ileum (whereas it plays only a minor role in the
rabbitjejunum;Munck&Munck,1992).AlthoughATB0,+
isgenerallyconsideredtobeprimarilylocatedinthedistal
small intestine and colon in many species (Munck &
Munck, 1992; Hatanaka et al. 2002) we found a higher
expression of ATB0,+ (albeit at the mRNA level) in the
duodenum than ileum in both the human tissue panel
and human biopsy samples (Fig.8). Therefore, although
ATB0,+ will not be involved in taurine absorption, it may
play a role in transport of both nutrients and orally active
drugs in proximal and distal regions of the human small
intestine (Nakanishi et al. 2001; Hatanaka et al. 2002).
The variation in the expression of the taurine trans-
porters, particularly PAT1, in the small intestine of
different species most likely represents adaptation to
dietary availability of taurine. The relative requirement
for dietary taurine versus endogenous synthesis, in
any particular animal or species, will vary with age,
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environment and physiological state but will generally
reﬂect the relative magnitudes of synthetic capacity
(cysteinesulﬁnate decarboxylase) and demand (due to
catabolism, biliary secretion and renal excretion). In
man, one of the major sinks for whole body taurine
content is in the conjugation of bile acids in the liver.
Interestingly, strong parallels can be made between the
relative dependence of certain species on dietary taurine
and their ability to utilize taurine in bile acid conjugation.
A progressive dependence upon dietary taurine has been
observed in the series: guinea pig, rat, monkey, human
and cat (Huxtable, 1992). Most vertebrates conjugate
bile acids exclusively to taurine although some placental
animals have adapted to use glycine wholly or partially
(Vessey, 1978; Huxtable, 1992). Cats conjugate taurine to
bile acids but have minimal capacity for taurine synthesis
making them reliant on diet (Hayes, 1988). This may
represent an adaptation to maximize use of the abundant
taurineincarnivorousdietswhichnegatestherequirement
for energy expenditure on taurine synthesis. Humans
conjugate bile acids to either taurine or glycine with the
ratio varying during development and in response to
changesindietarytaurinebutnotdietaryglycine(Garbutt
et al. 1971; Sturman, 1993). Interestingly, PAT1 can also
transport glycine (Thwaites et al. 1995; Chen et al. 2003).
However, compared to many other species, humans have
a low capacity for taurine synthesis and are still relatively
dependentupondietarysources(Laidlaw&Kopple,1987;
Huxtable, 1992). Rats conjugate bile acids exclusively
to taurine but, unlike cats, have signiﬁcant synthetic
capacity (Worden & Stipanuk, 1985) to generate endo-
genous taurine. In contrast, herbivores such as the guinea
pig and rabbit, whose diet is essentially devoid of taurine,
conjugate bile acids exclusively to glycine, presumably
reﬂecting an adaptive response to the relative taurine
deﬁciency in the liver (Vessey, 1978). Thus, it appears
that the relative dependence upon dietary (as opposed
to endogenous) taurine may reﬂect, at least in part, the
use of taurine as the conjugate in bile acid synthesis. As a
result,itseemslikelythattherelativecapacitiesofthesmall
intestine of different species will have adapted to, ﬁrstly,
maximize taurine absorption from diet and, secondly,
ensure the efﬁcient reabsorption of taurine following
deconjugation of bile salts (e.g. taurocholate) from the
intestinal lumen. In human and rat intestine, where a
requirementforluminaltaurineuptakeeitherfromdietary
orbiliarysourcesmightbeexpected,therearetwotaurine
transport systems at the small intestinal luminal surface:
PAT1, a low-afﬁnity, high-capacity transporter; and TauT,
a high-afﬁnity, very low-capacity transporter. In contrast,
in certain herbivorous mammals (guinea pig and rabbit)
with a diet essentially devoid of taurine and which do not
conjugatebileacidstotaurine,thelow-afﬁnity(PAT1-like)
transporterfortaurineseemstohavebeenlostanduptake
acrossthesmallintestinalbrush-bordermembranecanbe
accounted for by a TauT-like transporter (Miyamoto et al.
1989; Munck & Munck, 1992, 1994).
In conclusion, we have identiﬁed the key functional
characterictics of taurine transport via PAT1 and TauT
that will allow discrimination between these two carriers
in intestine and other tissues. Interpretation of data using
commercialmultipletissuepanelsislimited.However,the
relativecontributionsofPAT1andTauTtotaurineuptake
across the Caco-2 cell monolayers, plus relative estimates
of PAT1 and TauT transcript expression by real-time PCR
in human duodenal and ileal mucosal samples (Fig.8), as
well as Caco-2 cells, support a role for both transporters
in taurine absorption. The high-capacity PAT1 trans-
porter may be responsible for the bulk of taurine uptake
duringahigh-taurinemealwhereasthelow-capacityTauT
transporter may be more important for either supplying
taurine to the intestinal epithelium (e.g. as an osmolyte)
or for capturing taurine released between meals (e.g.
from sloughed cells) (Thwaites & Anderson, 2007). The
expression of both transporters in the distal intestine
indicates that both could play a role in reabsorption of
taurine deconjugated from bile acids by bacteria in distal
partsofthelumen.Howtherelativeexpressionlevelsofthe
two transporters vary spatially (e.g. along the crypt–villus
axis), developmentally and in response to changes in
diet,hormonallevelsorpharmacologicalregimes,requires
further investigation.
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